Fennec Pharmaceuticals Inc (FENC)

Cost of Revenue

$721.00K

Quarterly · Period ending: · USD

FENC logo

FENC Cost of Revenue

Latest reported$721.00K
FENC Quarterly Cost of Revenue ($0.00 → $721.00K)
High-resolution chart · PNG

FENC cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fennec Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
721,000
570,000
1,764,000
660,000
967,000
373,000
669,000
1,357,000
608,000
550,000
685,000
331,000
148,000
95,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.